American Oncology Network Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-13.2	-5.54	2.59	-0.11	21.95
Depreciation & Amortization	17.15	16.74	17.08	6.08	3.66
Share-Based Compensation	10.09	4.87	0	0.02	0.02
Other Operating Activities	10.39	-34.19	-26.46	-32.33	11.62
Operating Cash Flow	24.44	-18.12	-6.78	-26.34	37.25
Capital Expenditures	-11.81	-12.28	-7.19	-8.32	-12.22
Acquisitions	1.64	0.7	-0.01	-3.22	-0.93
Change in Investments	-107.88	-109.72	-15.27	-	-
Other Investing Activities	105.13	85.76	8.48	0.84	-1.52
Investing Cash Flow	-12.91	-35.53	-13.99	-10.69	-14.67
Common Stock Issued	0	65	0	25	28.5
Share Repurchases	-0.19	-9.57	0	0	0
Other Financing Activities	-1.25	-19.3	15.35	1.54	-12.24
Financing Cash Flow	-1.07	55.27	15.35	26.54	16.26
Net Cash Flow	10.46	1.61	-5.43	-10.49	38.83
Free Cash Flow	12.63	-30.4	-13.98	-34.66	25.02
Free Cash Flow Margin	0.95%	-2.38%	-1.22%	-3.67%	3.45%
Free Cash Flow Per Share	1.68	-4.55	-1.47	-3.64	2.63

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.